New Prostate Cancer Drug Shows Promise

According to a study which is published in the journal of Science, results of early tests on a new experimental drug bring hope to men diagnosed with the most aggressive form of prostate cancer.

Ten percent of men diagnosed with prostate cancer have an aggressive form of the disease.  The drug resistant form of the disease accounts for nearly all the 29,000 deaths among Americans every year.

In the study, the researchers showed that the new drug caused levels of the prostate specific antigen (PSA) to fall by at least 50% in 13 of 30 patients with advanced prostate cancer that had resisted other treatments.

Although more clinical studies are needed, the study has stirred interest among experts because it attacks the cancer in a new way.

Get free information about prostate cancer from the medical malpractice attorneys at Berger & Lagnese, LLC.